Dividends Calendar Earnings Calendar

AGLE | Aeglea BioTherapeutics, Inc.

Aeglea BioTherapeutics, Inc.
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Austin, Texas, United States

Trade prices

  • Volume:
  • Market Cap: 371.99M
  • Prev closed: 7.15
  • Open: 7.25
  • High: 7.32
  • Low: 7.05
  • 52 week low: 3.5
  • 52 week high: 11.38
  • Dividends:No Dividends

Next ER: March 22, 2021 



Top Stories (AGLE)

    Company Profile

    Aeglea BioTherapeutics is a late clinical-stage biotechnology company redefining the potential of human enzyme therapeutics to benefit people with rare and devastating metabolic diseases with limited treatment options. Aeglea's lead product candidate, pegzilarginase, is in a pivotal Phase 3 trial for the treatment of Arginase 1 Deficiency and has received both Rare Pediatric Disease and Breakthrough Therapy Designation. In the second quarter of 2020, the Company initiated a Phase 1/2 clinical trial of AGLE-177 for the treatment of Homocystinuria. AGLE-177 has also been granted Rare Pediatric Disease Designation. Aeglea has an active discovery platform focused on engineering small changes in human enzymes to have a big impact on the lives of patients and their families.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    May 11, 2021
    March 25, 2021- / -0.3071- / -
    November 5, 2020-0.2627 / -0.3917- / -
    August 11, 2020- / -0.43- / 8.55M
    May 12, 2020- / -0.55- / 8.4M
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Mar 19, 2021 7.89 8.08
    8.08
    7.40
    403.28K 5.48%
    Mar 18, 2021 7.48 7.58
    7.81
    7.45
    135.82K -3.61%
    Mar 17, 2021 7.76 7.57
    7.78
    7.47
    81.19K 1.31%
    Mar 16, 2021 7.66 7.79
    7.81
    7.37
    800.92K -2.42%
    Mar 15, 2021 7.85 8.02
    8.08
    7.82
    69.56K -1.26%
    Mar 12, 2021 7.95 8.21
    8.21
    7.94
    139.03K -4.68%
    Mar 11, 2021 8.34 8.14
    8.37
    8.03
    181.42K 3.99%
    Mar 10, 2021 8.02 8.07
    8.40
    8.02
    143.29K -1.72%
    Mar 9, 2021 8.16 7.81
    8.23
    7.73
    184.81K 5.15%
    Mar 8, 2021 7.76 7.51
    8.17
    7.51
    369.47K 7.03%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2013
    • Employees:75

    News

    News for (AGLE)

    This company doesn't provide a dividend.


    Talk about Aeglea BioTherapeutics, Inc. below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Mar 22, 2021 (Same day)

    snx tme stok xbit crmd uavs ayro blfs htbx axas sy cwco 


    Jump to (Finance sites)

    Research 

    Their Official Profiles 

    LinkedIn

    Other stocks 

    hpq orcl aap kmx azo jbl ctas tvpt ryaay aobc rh ntnx 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    How to Day Trade for a Living
    Buy on Amazon

    Very few careers can offer you the freedom, flexibility, and income that day trading does. As a day trader, you can live and work anywhere in the world. You can decide when to work and when not to work. You only answer to yourself. That is the life of the successful day trader. Many people aspire to it, but very few succeed.

    A Beginner's Guide to Trading Tools and Tactics, Money Management, Discipline and Trading Psychology